A novel local anti-colorectal cancer drug delivery system: negative lipidoid nanoparticles with a passive target via a size-dependent pattern
Authors:
- Feng WangFWFeng Wang
- Jianfeng ZhangJZJianfeng Zhang
- Yibing GuoYGYibing Guo
- Shaoqing JuSJShaoqing Ju
- Huimin WangHWHuimin Wang
- 21 August 2013
- journal article
- Published by IOP Publishing in Nanotechnology
- Vol. 24 (37) , 375101
Abstract
The nontoxic, targeted and effective delivery of nucleic acid drugs remains an important challenge for clinical development. Here, we describe a novel negative lipidoid nanoparticle delivery system, providing entrapment-based transfection agents for local delivery of siRNA to the colorectal cancer focus. The delivery system was synthesized with lipidoid material 98N12-5(1), mPEG2000-C12/C14 glyceride and cholesterol at a desired molar ratio to realize the anionic surface charge of particles, which could alleviate to a larger degree the inflammatory response and immune stimulation of the organism, embodying dramatic biocompatibility. In particular, mPEG2000-C12/C14 glyceride was selected to ameliorate the stability of the delivery system and protection of nucleic acids by extending the tail length of the carbons, crucial also to neutralize the positive charge of 98N12-5(1) to form a resultant anionic particle. In vivo experiments revealed that a particle size of 90 nm perfectly realized a passive target in a size-dependent manner and did not affect the function of the liver and kidneys by a local delivery method, enema. We clarified that the uptake of negative lipidoid nanoparticles internalized through a lipid raft endocytotic pathway with low cytotoxicity, strong biocompatibility and high efficacy. This study suggests that negative lipidoid nanoparticles with enema delivery constitute, uniquely and appropriately, a local anti-colorectal cancer nucleic acid drug delivery platform, and the application of similar modes may be feasible in other therapeutic settings.Keywords
This publication has 35 references indexed in Scilit:
- Biocompatibility of engineered nanoparticles for drug deliveryJournal of Controlled Release, 2013
- Cationic lipid-mediated nucleic acid delivery: beyond being cationicChemistry and Physics of Lipids, 2010
- Nature as a source of inspiration for cationic lipid synthesisGenetica, 2009
- On the mechanisms of biocompatibilityBiomaterials, 2008
- A combinatorial library of lipid-like materials for delivery of RNAi therapeuticsNature Biotechnology, 2008
- Interfering with disease: a progress report on siRNA-based therapeuticsNature Reviews Drug Discovery, 2007
- Administration in non-human primates of escalating intravenous doses of targeted nanoparticles containing ribonucleotide reductase subunit M2 siRNAProceedings of the National Academy of Sciences, 2007
- Cell type–specific delivery of siRNAs with aptamer-siRNA chimerasNature Biotechnology, 2006
- RNAi-mediated gene silencing in non-human primatesNature, 2006
- An siRNA-based microbicide protects mice from lethal herpes simplex virus 2 infectionNature, 2005